+1 800-759-9305
Sonoma Pharmaceuticals Logo

  • Microcyn Technology
    • How it works
    • Approvals
    • Literature
    • Patents
    • EN Testing
  • Partners
  • Products
    • Over the Counter
    • Wound Care
    • Dermatology
    • Decontamination Solution
    • Nasal and Eye Care
    • Oral and Dental Care
    • Podiatry
    • Animal Health
    • Surface Disinfectants
  • Investors
  • Shop Now
  • Facilities
    • Manufacturing Facility
    • Sonoma Europe
  • About us
    • Mission and vision
    • Business Development
    • Leadership team
  • Careers
  • Contact

Press Releases

Investors
  • Overview
  • Business Development
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

Jan 31, 2023

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

Jan 25, 2023

Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas

Jan 4, 2023

Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results

Nov 14, 2022

Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States

Oct 27, 2022

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany

Oct 6, 2022

Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results

Aug 11, 2022

Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supply

Aug 2, 2022

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results

Jul 13, 2022

Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19

Jun 1, 2022
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...39
Next
  • Partnership/Distribution Opportunities
  • Microcyn Technology
  • Contact
  • Partners
  • Investors
  • Data
  • Access for All
  • Europe
  • Wound Care
  • Dermatology US
  • Decontamination Solution
  • Nasal and Eye Care
  • Oral and Dental Care
  • Microcyn AH
  • Surface Disinfectants
Follow Us
Enter your email address to join our email list.

Copyright 2023 Sonoma Pharmaceuticals, Inc. • Terms and Conditions • Privacy Policy